{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:03:23Z","timestamp":1784394203353,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"DOI":"10.1007\/s00586-026-10205-x","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T16:22:08Z","timestamp":1784391728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Can glucagon-like peptide-1 receptor agonists affect outcomes after spine surgery? A systematic review and meta-analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-4354","authenticated-orcid":false,"given":"Sathish","family":"Muthu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhu Krishnan","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhibin Vikash","family":"Kolarpatti Ponnusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella Sherin","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish Kumar","family":"Rajappan Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khan","family":"Sharun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Hiatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakthivel Rajan","family":"Rajaram Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Theiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"10205_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR et al (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet 394:121\u2013130. https:\/\/doi.org\/10.1016\/S0140-6736(19)31149-3","journal-title":"Lancet"},{"key":"10205_CR2","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A et al (2016) Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 375:1834\u20131844. https:\/\/doi.org\/10.1056\/NEJMoa1607141","journal-title":"N Engl J Med"},{"key":"10205_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K et al (2016) Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 375:311\u2013322. https:\/\/doi.org\/10.1056\/NEJMoa1603827","journal-title":"N Engl J Med"},{"key":"10205_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S et al (2021) Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 384:989\u20131002. https:\/\/doi.org\/10.1056\/NEJMoa2032183","journal-title":"N Engl J Med"},{"key":"10205_CR5","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1001\/jama.2024.7112","volume":"331","author":"JM Lee","year":"2024","unstructured":"Lee JM, Sharifi M, Oshman L et al (2024) Dispensing of Glucagon-Like Peptide-1 Receptor Agonists to Adolescents and Young Adults, 2020\u20132023. JAMA 331:2041\u20132043. https:\/\/doi.org\/10.1001\/jama.2024.7112","journal-title":"JAMA"},{"key":"10205_CR6","doi-asserted-by":"publisher","first-page":"106789","DOI":"10.1016\/j.ijsu.2022.106789","volume":"104","author":"M Luo","year":"2022","unstructured":"Luo M, Cao Q, Wang D et al (2022) The impact of diabetes on postoperative outcomes following spine surgery: A meta-analysis of 40 cohort studies with 2.9 million participants. Int J Surg 104:106789. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106789","journal-title":"Int J Surg"},{"key":"10205_CR7","doi-asserted-by":"publisher","first-page":"e28836","DOI":"10.1097\/MD.0000000000028836","volume":"101","author":"X Zhang","year":"2022","unstructured":"Zhang X, Liu P, You J (2022) Risk factors for surgical site infection following spinal surgery: A meta-analysis. Med (Baltim) 101:e28836. https:\/\/doi.org\/10.1097\/MD.0000000000028836","journal-title":"Med (Baltim)"},{"key":"10205_CR8","doi-asserted-by":"publisher","first-page":"E347","DOI":"10.1097\/BRS.0000000000005396","volume":"50","author":"MP Steinmetz","year":"2025","unstructured":"Steinmetz MP, O\u2019Toole JE, Harrop JS et al (2025) Adverse Impact of Diabetes on Spine Fusion and Patient-Reported Outcomes. Spine 50:E347\u2013E360. https:\/\/doi.org\/10.1097\/BRS.0000000000005396","journal-title":"Spine"},{"key":"10205_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/BRS.0000000000005395","volume":"50","author":"JE O\u2019Toole","year":"2025","unstructured":"O\u2019Toole JE, Sasso RC, Harrop JS et al (2025) Adverse Impact of Obesity on Lumbar Spine Fusion, Patient-reported Outcomes and Costs: A Systematic Review and Meta-analysis. Spine 50:1208. https:\/\/doi.org\/10.1097\/BRS.0000000000005395","journal-title":"Spine"},{"key":"10205_CR10","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s00198-025-07664-1","volume":"36","author":"L Karam","year":"2025","unstructured":"Karam L, Mabilleau G, Paccou J (2025) Effects of Glucagon-Like Peptide-1 receptor agonists on bone health in people living with obesity. Osteoporos Int 36:2115\u20132126. https:\/\/doi.org\/10.1007\/s00198-025-07664-1","journal-title":"Osteoporos Int"},{"key":"10205_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.08.046","author":"Q Fang","year":"2025","unstructured":"Fang Q, Li G, Liu P et al (2025) GLP-1 and GIP: Magic bullet for musculoskeletal diseases? J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2025.08.046","journal-title":"J Adv Res"},{"key":"10205_CR12","doi-asserted-by":"publisher","first-page":"117338","DOI":"10.1016\/j.bone.2024.117338","volume":"192","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Chen G, Wang W et al (2025) Association of Glucagon-like peptide-1 receptor agonists use with fracture risk in type 2 diabetes: A meta-analysis of randomized controlled trials. Bone 192:117338. https:\/\/doi.org\/10.1016\/j.bone.2024.117338","journal-title":"Bone"},{"key":"10205_CR13","unstructured":"American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists. https:\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2023\/06\/american-society-of-anesthesiologists-consensus-based-guidance-on-preoperative. Accessed 17 Jan 2026"},{"key":"10205_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00464-024-11263-2","volume":"39","author":"TL Kindel","year":"2025","unstructured":"Kindel TL, Wang AY, Wadhwa A et al (2025) Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surg Endosc 39:180\u2013183. https:\/\/doi.org\/10.1007\/s00464-024-11263-2","journal-title":"Surg Endosc"},{"key":"10205_CR15","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.cgh.2024.10.003","volume":"23","author":"TL Kindel","year":"2025","unstructured":"Kindel TL, Wang AY, Wadhwa A et al (2025) Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 23:2083\u20132085. https:\/\/doi.org\/10.1016\/j.cgh.2024.10.003","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10205_CR16","unstructured":"Most Patients Can Continue Diabetes Weight Loss GLP-1 Drugs Before Surgery, Those at Highest Risk for GI Problems Should Follow Liquid Diet Before Procedure. https:\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2024\/10\/new-multi-society-glp-1-guidance. Accessed 17 Jan 2026"},{"key":"10205_CR17","doi-asserted-by":"publisher","first-page":"e00098","DOI":"10.1227\/neuprac.0000000000000098","volume":"5","author":"H Abdulrazeq","year":"2024","unstructured":"Abdulrazeq H, Taman M, Ali R et al (2024) GLP-1 Receptor Agonists: Beyond Diabetes-What the Neurosurgeon Needs to Know. Neurosurg Pract 5:e00098. https:\/\/doi.org\/10.1227\/neuprac.0000000000000098","journal-title":"Neurosurg Pract"},{"key":"10205_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.21037\/jss-24-152","volume":"11","author":"D Barkyoumb","year":"2025","unstructured":"Barkyoumb D, Muhammad F, Smith ZA, Shakir HJ (2025) Preoperative optimization of obese spine patients with GLP-1 receptor agonists: enhancing surgery and improving outcomes. J Spine Surg Hong Kong 11:339\u2013346. https:\/\/doi.org\/10.21037\/jss-24-152","journal-title":"J Spine Surg Hong Kong"},{"key":"10205_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/BSD.0000000000001888","author":"JW Connelly","year":"2025","unstructured":"Connelly JW, Narayanan R, Ezeonu T et al (2025) Narrative Review of Perioperative Glucagon-like Peptide-1 (GLP-1) Agonists in Spine Surgery. Clin Spine Surg. https:\/\/doi.org\/10.1097\/BSD.0000000000001888","journal-title":"Clin Spine Surg"},{"key":"10205_CR20","doi-asserted-by":"publisher","unstructured":"Younus I, Garcia de Oliveira R, Fujii T et al (2025) Are GLP-1 Receptor Agonists Safe in Spine Surgery: A Systematic Review. https:\/\/doi.org\/10.1097\/BRS.0000000000005466. Spine","DOI":"10.1097\/BRS.0000000000005466"},{"key":"10205_CR21","doi-asserted-by":"publisher","first-page":"e93065","DOI":"10.7759\/cureus.93065","volume":"17","author":"M Zahed","year":"2025","unstructured":"Zahed M, Elmesalmi M, Al-Kharouf KF et al (2025) Efficacy and Safety of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Spinal Fusion Outcomes: A Comprehensive Meta-Analysis. Cureus 17:e93065. https:\/\/doi.org\/10.7759\/cureus.93065","journal-title":"Cureus"},{"key":"10205_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.xnsj.2025.100835","author":"FC Ononogbu-Uche","year":"2026","unstructured":"Ononogbu-Uche FC, Toussaint F, Saleh AW et al (2026) Do GLP-1 agonists affect perioperative risk in spine surgery? A systematic review and meta-analysis. North Am Spine Soc J NASSJ. https:\/\/doi.org\/10.1016\/j.xnsj.2025.100835. 25:","journal-title":"North Am Spine Soc J NASSJ"},{"key":"10205_CR23","doi-asserted-by":"publisher","unstructured":"Fano A, Oris RJ, Dalton J et al (2025) GLP-1 Agonist Use Leads to Earlier Return of Bowel Function Following Lumbar Fusion. https:\/\/doi.org\/10.1097\/BRS.0000000000005598. Spine","DOI":"10.1097\/BRS.0000000000005598"},{"key":"10205_CR24","doi-asserted-by":"publisher","first-page":"E579","DOI":"10.1097\/BSD.0000000000001800","volume":"38","author":"A Ghali","year":"2025","unstructured":"Ghali A, Lawand J, Mitchell P et al (2025) The Use of Semaglutide in Patients Undergoing Lumbar Fusion Does not Increase 90-Day Medical or 1-Year Implant Complications. Clin Spine Surg 38:E579\u2013E584. https:\/\/doi.org\/10.1097\/BSD.0000000000001800","journal-title":"Clin Spine Surg"},{"key":"10205_CR25","doi-asserted-by":"publisher","unstructured":"Kesaria AA, Marzook FA, Glover JM, Alijanipour P (2025) Association Between Preoperative GLP-1 Receptor Analog Use and Postoperative Complications and Mortality Following Lumbar Fusion Surgery. Glob Spine J 21925682251391693. https:\/\/doi.org\/10.1177\/21925682251391693","DOI":"10.1177\/21925682251391693"},{"key":"10205_CR26","doi-asserted-by":"publisher","unstructured":"Kishan A, Khela HS, Carayannopoulos NL et al (2025) Association of Glucagon-like Peptide-1 Receptor Agonist Use with Complications Following Thoracic and\/or Lumbar Spinal Fusion for Degenerative Spine Disease: A BMI-Stratified Retrospective Study. https:\/\/doi.org\/10.1097\/BRS.0000000000005494. Spine","DOI":"10.1097\/BRS.0000000000005494"},{"key":"10205_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.spinee.2024.10.011","volume":"25","author":"AE Seddio","year":"2025","unstructured":"Seddio AE, Gouzoulis MJ, Vasudevan RS et al (2025) Semaglutide utilization associated with reduced 90-day postoperative complications following single-level posterior lumbar fusion for patients with type II diabetes. Spine J Off J North Am Spine Soc 25:485\u2013493. https:\/\/doi.org\/10.1016\/j.spinee.2024.10.011","journal-title":"Spine J Off J North Am Spine Soc"},{"key":"10205_CR28","doi-asserted-by":"publisher","first-page":"124751","DOI":"10.1016\/j.wneu.2025.124751","volume":"206","author":"NC Bank","year":"2025","unstructured":"Bank NC, Whittingslow D, Duggan S et al (2025) The Effect of GLP-1 Receptor Agonists on Reoperation Following Anterior Cervical Discectomy and Fusion. World Neurosurg 206:124751. https:\/\/doi.org\/10.1016\/j.wneu.2025.124751","journal-title":"World Neurosurg"},{"key":"10205_CR29","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/BRS.0000000000005283","volume":"50","author":"JM Wiener","year":"2025","unstructured":"Wiener JM, Sanghvi PA, Vlastaris K et al (2025) Glucagon-Like Peptide-1 Receptor Agonist Medications Alter Outcomes of Spine Surgery: A Study Among Over 15,000 Patients. Spine 50:871\u2013880. https:\/\/doi.org\/10.1097\/BRS.0000000000005283","journal-title":"Spine"},{"key":"10205_CR30","doi-asserted-by":"publisher","unstructured":"Stump K, Kelleher S, Hannah TC et al (2025) Perioperative Glucagon-like Peptide-1 Receptor Agonist Use Is Associated With Lower Pseudoarthrosis Rates Following Long-Segment Spinal Deformity Correction: A Propensity-Matched Analysis. Glob Spine J 21925682251396965. https:\/\/doi.org\/10.1177\/21925682251396965","DOI":"10.1177\/21925682251396965"},{"key":"10205_CR31","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.spinee.2025.03.023","volume":"25","author":"MK Ng","year":"2025","unstructured":"Ng MK, Mastrokostas PG, Mastrokostas LE et al (2025) Semaglutide use is associated with higher rates of pseudarthrosis and dysphagia in patients undergoing posterior cervical fusion. Spine J Off J North Am Spine Soc 25:1974\u20131980. https:\/\/doi.org\/10.1016\/j.spinee.2025.03.023","journal-title":"Spine J Off J North Am Spine Soc"},{"key":"10205_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4103\/jcvjs.jcvjs_156_25","volume":"16","author":"MK Ng","year":"2025","unstructured":"Ng MK, Mastrokostas PG, Rodriguez AN et al (2025) Semaglutide use before single-level lumbar fusion associated with fewer readmissions and 90-day costs. J Craniovertebral Junction Spine 16:401\u2013407. https:\/\/doi.org\/10.4103\/jcvjs.jcvjs_156_25","journal-title":"J Craniovertebral Junction Spine"},{"key":"10205_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/BSD.0000000000001775","volume":"38","author":"SK Vatsia","year":"2025","unstructured":"Vatsia SK, Levidy MF, Rowe ND et al (2025) Fusion Outcomes of GLP-1 Agonist Therapy in Multilevel Cervical Spinal Fusion: A Propensity-Matched Analysis. Clin Spine Surg 38:213\u2013216. https:\/\/doi.org\/10.1097\/BSD.0000000000001775","journal-title":"Clin Spine Surg"},{"key":"10205_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jor.2025.05.018","volume":"65","author":"S Tummala","year":"2025","unstructured":"Tummala S, Gibbs DC, Chavarria J et al (2025) GLP-1 receptor agonist use in elective lumbar spine surgery: Reduced pseudarthrosis rates and favorable safety profile. J Orthop 65:227\u2013232. https:\/\/doi.org\/10.1016\/j.jor.2025.05.018","journal-title":"J Orthop"},{"key":"10205_CR35","doi-asserted-by":"publisher","first-page":"100612","DOI":"10.1016\/j.xnsj.2025.100612","volume":"22","author":"SN Goldman","year":"2025","unstructured":"Goldman SN, Mani K, Scharfenberger T et al (2025) Glucagon-like peptide-1 receptor agonist use prior to spinal surgery results in reduced postoperative length of stay: A propensity-score matched analysis. North Am Spine Soc J 22:100612. https:\/\/doi.org\/10.1016\/j.xnsj.2025.100612","journal-title":"North Am Spine Soc J"},{"key":"10205_CR36","doi-asserted-by":"publisher","first-page":"108952","DOI":"10.1016\/j.clineuro.2025.108952","volume":"254","author":"SI Khalid","year":"2025","unstructured":"Khalid SI, Mirpuri P, Massaad E et al (2025) The impact of semaglutide use for weight loss on transforaminal lumbar interbody fusion outcomes. Clin Neurol Neurosurg 254:108952. https:\/\/doi.org\/10.1016\/j.clineuro.2025.108952","journal-title":"Clin Neurol Neurosurg"},{"key":"10205_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2024.6.SPINE24141","volume":"42","author":"SI Khalid","year":"2025","unstructured":"Khalid SI, Massaad E, Thomson K, Shin JH (2025) Semaglutide exposure and its association with adverse outcomes in diabetic patients undergoing transforaminal lumbar interbody fusion for lumbar degenerative disc disease. J Neurosurg Spine 42:1\u20138. https:\/\/doi.org\/10.3171\/2024.6.SPINE24141","journal-title":"J Neurosurg Spine"},{"key":"10205_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/BRS.0000000000005099","volume":"50","author":"X Tao","year":"2025","unstructured":"Tao X, Ranganathan S, Van Halm-Lutterodt N et al (2025) No Difference in Short-term Surgical Outcomes From Semaglutide Treatment for Type 2 Diabetes Mellitus After Cervical Decompression and Fusion: A Propensity Score-matched Analysis. Spine 50:515\u2013521. https:\/\/doi.org\/10.1097\/BRS.0000000000005099","journal-title":"Spine"},{"key":"10205_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1227\/neu.0000000000003291","volume":"97","author":"V Agrawal","year":"2024","unstructured":"Agrawal V, Amasa S, Karabacak M, Margetis K (2024) Perioperative Glucagon-Like Peptide-1 Agonist Use and Rates of Pseudarthrosis After Single-Level Lumbar Fusion: A Large Retrospective Cohort Study. Neurosurgery 97:91\u201397. https:\/\/doi.org\/10.1227\/neu.0000000000003291","journal-title":"Neurosurgery"},{"key":"10205_CR40","doi-asserted-by":"publisher","unstructured":"Chang Y, Chi K-Y, Song J et al (2025) Association of GLP-1 Receptor Agonist Use With Risk of Lumbar Degenerative Disease and Spine Surgery in Patients With Type 2 Diabetes: A Propensity Score-matched Cohort Study. Glob Spine J 21925682251383170. https:\/\/doi.org\/10.1177\/21925682251383170","DOI":"10.1177\/21925682251383170"},{"key":"10205_CR41","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.spinee.2025.07.010","volume":"26","author":"Y Chang","year":"2026","unstructured":"Chang Y, Chi K-Y, Song J, Lin H-M (2026) Association between glucagon-like peptide-1 receptor agonists and nonfusion risk after single-level anterior cervical discectomy and fusion. Spine J Off J North Am Spine Soc 26:158\u2013162. https:\/\/doi.org\/10.1016\/j.spinee.2025.07.010","journal-title":"Spine J Off J North Am Spine Soc"},{"key":"10205_CR42","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1097\/JS9.0000000000002492","volume":"111","author":"Y Chang","year":"2025","unstructured":"Chang Y, Lin H-M, Chi K-Y et al (2025) The impact of semaglutide on fusion rates following posterior lumbar fusion surgery in patients with type 2 diabetes. Int J Surg Lond Engl 111:4898\u20134900. https:\/\/doi.org\/10.1097\/JS9.0000000000002492","journal-title":"Int J Surg Lond Engl"},{"key":"10205_CR43","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"10205_CR44","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"10205_CR45","unstructured":"Newcastle-Ottawa Scale (NOS) | Ottawa Hospital Research Institute https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale. Accessed 17 Jan 2026"},{"key":"10205_CR46","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jspi.2009.09.017","volume":"140","author":"D Jackson","year":"2010","unstructured":"Jackson D, Bowden J, Baker R (2010) How does the DerSimonian and Laird procedure for random effects meta-analysis compare with its more efficient but harder to compute counterparts? J Stat Plan Inference 140:961\u2013970. https:\/\/doi.org\/10.1016\/j.jspi.2009.09.017","journal-title":"J Stat Plan Inference"},{"key":"10205_CR47","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.bja.2024.01.001","volume":"132","author":"ML van Zuylen","year":"2024","unstructured":"van Zuylen ML, Siegelaar SE, Plummer MP et al (2024) Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration. Br J Anaesth 132:644\u2013648. https:\/\/doi.org\/10.1016\/j.bja.2024.01.001","journal-title":"Br J Anaesth"},{"key":"10205_CR48","doi-asserted-by":"publisher","first-page":"111871","DOI":"10.1016\/j.jclinane.2025.111871","volume":"104","author":"X-Y Li","year":"2025","unstructured":"Li X-Y, Jin Y, Feng X-Y et al (2025) Perioperative management of patients on GLP-1 receptor agonists: Risks, recommendations, and future directions-A narrative review. J Clin Anesth 104:111871. https:\/\/doi.org\/10.1016\/j.jclinane.2025.111871","journal-title":"J Clin Anesth"},{"key":"10205_CR49","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/medicina58020224","volume":"58","author":"I Daniilopoulou","year":"2022","unstructured":"Daniilopoulou I, Vlachou E, Lambrou GI et al (2022) The Impact of GLP1 Agonists on Bone Metabolism: A Systematic Review. Med (Mex) 58:224. https:\/\/doi.org\/10.3390\/medicina58020224","journal-title":"Med (Mex)"},{"key":"10205_CR50","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12178-025-09978-3","volume":"18","author":"A Gatto","year":"2025","unstructured":"Gatto A, Liu K, Milan N, Wong S (2025) The Effects of GLP-1 Agonists on Musculoskeletal Health and Orthopedic Care. Curr Rev Musculoskelet Med 18:469\u2013480. https:\/\/doi.org\/10.1007\/s12178-025-09978-3","journal-title":"Curr Rev Musculoskelet Med"},{"key":"10205_CR51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.yexcr.2017.09.018","volume":"360","author":"X Wu","year":"2017","unstructured":"Wu X, Li S, Xue P, Li Y (2017) Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)\/protein kinase B (AKT), extracellular signal-related kinase (ERK)1\/2, and cAMP\/protein kinase A (PKA) signaling pathways involving \u03b2-catenin. Exp Cell Res 360:281\u2013291. https:\/\/doi.org\/10.1016\/j.yexcr.2017.09.018","journal-title":"Exp Cell Res"},{"key":"10205_CR52","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.3390\/ijms26073050","volume":"26","author":"P Karakasis","year":"2025","unstructured":"Karakasis P, Patoulias D, Theofilis P et al (2025) GLP-1 Receptor Agonists and Myocardial Perfusion: Bridging Mechanisms to Clinical Outcomes. Int J Mol Sci 26:3050. https:\/\/doi.org\/10.3390\/ijms26073050","journal-title":"Int J Mol Sci"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-026-10205-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00586-026-10205-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-026-10205-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T16:22:09Z","timestamp":1784391729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00586-026-10205-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":52,"alternative-id":["10205"],"URL":"https:\/\/doi.org\/10.1007\/s00586-026-10205-x","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}